Cargando…
Differential effects of Vav‐promoter‐driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis
Overexpression of BCLX and BFL1/A1 has been reported in various human malignancies and is associated with poor prognosis and drug resistance, identifying these prosurvival BCL2 family members as putative drug targets. We have generated transgenic mice that express human BFL1 or human BCLX protein th...
Autores principales: | Tuzlak, Selma, Haschka, Manuel D., Mokina, Anna‐Maria, Rülicke, Thomas, Cory, Suzanne, Labi, Verena, Villunger, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947286/ https://www.ncbi.nlm.nih.gov/pubmed/29498802 http://dx.doi.org/10.1111/febs.14426 |
Ejemplares similares
-
TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells
por: Schoeler, Katia, et al.
Publicado: (2019) -
A1/Bfl-1 in leukocyte development and cell death
por: Ottina, Eleonora, et al.
Publicado: (2012) -
Mnt modulates Myc-driven lymphomagenesis
por: Campbell, Kirsteen J, et al.
Publicado: (2017) -
Checkpoint kinase 1 is essential for normal B cell development and lymphomagenesis
por: Schuler, Fabian, et al.
Publicado: (2017) -
Cancer‐associated mutations in VAV1 trigger variegated signaling outputs and T‐cell lymphomagenesis
por: Robles‐Valero, Javier, et al.
Publicado: (2021)